Karina Vázquez-Arreguín

机构：The University of Texas MD Anderson Cancer Center, Augusta University Health · ORCID：0000-0003-0846-0899

发表论文 42 篇 · 总被引 470 次 · h-index 8

代表论文

• Oncolytic HSV and cancer drug interactions: Current clinical status and future directions (2025 · Molecular Therapy · 被引 10)
• Engineering a novel HSV-1 strain for oncolytic therapy of solid tumors (2025 · Molecular Therapy Oncology · 被引 4)
• Novel synthetic peptide-based vaccine shows promise against prostate cancer (2025 · Molecular Therapy Oncology · 被引 2)
• Engineered extracellular vesicles targeting BACE1 reduces amyloid-beta plaque formation in a genetic mouse model of Alzheimer’s Disease (2026 · bioRxiv (Cold Spring Harbor Laboratory))
• Abstract 355: Co-expression of FIH1 and IL-12 in oncolytic HSV-1 blocks Notch signaling and enhances anti-tumor immunity. (2026 · Cancer Research)
• Table S1 from Oncolytic HSV-1–Mediated JAG1 Blockade Induces Glioma Senescence-Associated Secretory Phenotype to Increase Macrophage Activation and Cetuximab-Mediated Senolysis (2026)